The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants

Professor Gregory Lip; Flemming Skjøth; Peter Brønnum Nielsen; Jette Nordstrøm Kjældgaard; Torben Bjerregaard Larsen

doi:10.1016/j.amjmed.2017.11.046

Back

The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants

Article 2017 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2017

P4567Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs)

Peter Brønnum Nielsen, F Skjoeth, Torben Bjerregaard Larsen, Jette Nordstrøm Kjældgaard, Professor Gregory Lip

Article2021

Comparison of the HAS-BLED, ORBIT and ATRIA bleeding risk scores in 399,344 patients with atrial fibrillation and cancer

Daniele Pastori, A Marang, Arnaud Bisson, Julien Herbert, Professor Gregory Lip, Laurent Fauchier

Article2021

Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding

Soonil Kwon, So-Ryoung Lee, Eue-Keun Choi, Euijae Lee, Jin‐Hyung Jung, Kyungdo Han, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip

Article2016

Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life

Michela Giustozzi, Maria Cristina Vedovati, Paolo Verdecchia, Lucia Pierpaoli, Melina Verso, Serenella Conti, F Cianella, Emanuela Marchesini, Esmeralda Filippucci, Giancarlo Agnelli, Cecilia Becattini

Article2019

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease

Inki Moon, So-Ryoung Lee, Eue-Keun Choi, Euijae Lee, Jin‐Hyung Jung, Kyungdo Han, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip